Related Experiment Video

Updated: May 29, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Myocardial regeneration in heart failure: integrated development of biological therapeutic approaches

Jesus Herreros1, Juan Bustamante

  • 1Department of Cardiovascular Surgery, Valdecilla University Hospital, Santander, Spain. jesus.herreros@gmail.com.

Expert Review of Cardiovascular Therapy
|September 1, 2011
PubMed

Insights

Heart failure is a growing global health crisis. This review updates knowledge on heart failure physiopathology and therapeutic strategies, including cellular therapy and immunomodulation.

Area of Science:

  • Cardiology
  • Regenerative Medicine

Background:

  • Heart failure is a significant and increasing health burden in Western countries, exacerbated by an aging population and lifestyle factors.
  • Despite optimal medical care, advanced heart failure patients face high mortality rates, necessitating novel therapeutic approaches.
  • Understanding physiopathological mechanisms is crucial for developing new treatment strategies.

Purpose of the Study:

  • To provide an updated overview of the latest concepts in heart failure physiopathology and humoral response.
  • To review recent advancements in therapeutic approaches for heart failure, excluding surgical treatments.
  • To highlight emerging fields such as myocardial regeneration, tissue engineering, and immunomodulation.

Main Methods:

  • Review of current literature on heart failure physiopathology.
  • Analysis of recent developments in cellular therapy and tissue engineering for myocardial regeneration.
  • Examination of advances in immunomodulation for heart failure treatment.

Main Results:

  • New therapeutic targets and research avenues have emerged from a better understanding of heart failure.
  • Cellular therapy, tissue engineering, and immunomodulation show promise for improving heart failure prognosis.
  • A multidisciplinary approach remains essential for complex heart failure management.

Conclusions:

  • Continued research into heart failure mechanisms is vital for therapeutic innovation.
  • Emerging regenerative and immunomodulatory strategies offer potential for improved patient outcomes.
  • Integrating novel therapies with existing multidisciplinary care models is key to addressing the heart failure epidemic.

More Related Videos

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...